Zimmer Biomet-RibFix Titan Study for Rib Fractures
This study is looking at the safety and effectiveness of the RibFix Titan™ device for people with rib fractures. The device helps to fix, stabilize, or fuse broken ribs. The main goal is to see how safe the RibFix Titan™ is by checking for any reoperations (additional surgeries) needed within 90 days after the device is put in. Researchers will also look at how well the device works to heal the fractures and how it affects your recovery, including how long you stay in the hospital. You might be able to join if you are at least 18 years old and need surgery for rib fractures. The current recruitment status is unclear.
- Study design
- This is an observational study, meaning researchers will watch and collect information about patients who receive the RibFix Titan™ device. It plans to include 54 participants.
- What's involved
- You would have data collected before surgery, during surgery, and at 14 days, 45 days, 90 days, and 1 year after surgery.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed for 1 year after their surgery.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Zimmer Biomet-RibFix Titan
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Hillary Overholser · STUDY_DIRECTOR · Zimmer Biomet
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Evaluation of Patient Safety90 days
Assessment of safety by analyzing reoperation rates related to the RibFix Titan™ at 90 days post-implantation. A reoperation will be considered any additional surgical procedure to revise, adjust, or replace the subject device's components and/or any surgical procedure to manage complications directly caused by the device.